174 related articles for article (PubMed ID: 6637176)
1. [Complications in the treatment of chronic glomerulonephritis].
Sinn W; Schmicker R; Klinkmann H
Z Urol Nephrol; 1983 Aug; 76(8):497-502. PubMed ID: 6637176
[TBL] [Abstract][Full Text] [Related]
2. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
[TBL] [Abstract][Full Text] [Related]
3. [Effect of immunosuppressive, anticoagulant and anti-inflammatory agents on experimental glomerulonephritis. VI. Encorton, immuran and cyclophosphamide].
Tyszkiewicz Z; Gawlik Z; Lewandowska T; Juska D
Patol Pol; 1984; 35(1):105-14. PubMed ID: 6493817
[No Abstract] [Full Text] [Related]
4. Immunosuppression for proliferative glomerulonephritis.
N Engl J Med; 1971 Nov; 285(21):1204-5. PubMed ID: 5096650
[No Abstract] [Full Text] [Related]
5. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of primary chronic glomerulonephritis with a triple combination of prednisone, azathioprine and a nitrogen mustard derivative].
Traver JA; Guajardo DS; Botella J
Rev Clin Esp; 1975 May; 137(4):321-5. PubMed ID: 1144863
[No Abstract] [Full Text] [Related]
7. [Dangers and limits of immunosuppressive therapy in chronic kidney diseases].
Schwaar R; Natusch R; Scholz D
Dtsch Gesundheitsw; 1971 May; 26(19):868-71. PubMed ID: 5578166
[No Abstract] [Full Text] [Related]
8. Cytostatic treatment of glomerular diseases. V. Treatment of glomerulonephritis with cyclophosphamide plus prednisone, azathioprine plus prednisone and cyclophosphamide as monotherapy. A comparative study. A report from a Copenhagen Study Group of Renal Diseases.
Brahm M; Balsløv JT; Brammer M; Brun C; Gerstoft J; Jørgensen HE; Kamper A; Larsen S; Lorenzen I; Thomsen AC
Acta Med Scand; 1988; 224(6):605-10. PubMed ID: 3061292
[TBL] [Abstract][Full Text] [Related]
9. Long-term steroid-immunosuppressive treatment of the childhood nephrotic syndrome.
Pachioli R; Genova R
Pediatrics; 1971 Apr; 47(4):731-6. PubMed ID: 4326172
[No Abstract] [Full Text] [Related]
10. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
Duman VL; Shkerina LI; Shilov EM
Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
[TBL] [Abstract][Full Text] [Related]
11. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
Knotková V; Nĕmecek K; Tarayeva IE; Krasnova TN
Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
[TBL] [Abstract][Full Text] [Related]
12. [Strategy of immunosuppressants usage for subjects with loss of renal function and infection control on RPGN].
Yoshida M
Nihon Jinzo Gakkai Shi; 2009; 51(2):114-20. PubMed ID: 19378797
[No Abstract] [Full Text] [Related]
13. Blastic transformation of lymphocytes in in vitro cultures during immunosuppressive therapy in patients with glomerulonephritis.
Szewczyk Z; Klinger M; Melcer H; Falkiewicz K
Arch Immunol Ther Exp (Warsz); 1975; 23(3):367-78. PubMed ID: 1217964
[TBL] [Abstract][Full Text] [Related]
14. [Glomerulonephritis therapy. Immunosuppression or coagulation inhibitors - a comparison].
Schmitt E; Sinn W; Lakner V; Ratner M; Tomilina N
Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 45-8. PubMed ID: 7467565
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of chronic glomerulonephritis with cytostatics].
Tareeva IE; Gordovskaia NB; Gladskikh OP; Ivanov AA; Krasnova TN
Ter Arkh; 1989; 61(6):9-14. PubMed ID: 2799726
[TBL] [Abstract][Full Text] [Related]
16. [Results of the treatment of mesangiocapillary glomerulonephritis].
Rodríguez JA; Olmos A; Ferrer E; Mauri JM; Capdevilla L; Codina S; Alsina J; Camps J; Piera L
Rev Clin Esp; 1975 Dec; 139(5):415-22. PubMed ID: 1215585
[No Abstract] [Full Text] [Related]
17. [Treatment of chronic glomerulonephritis using indomethacin and small doses of cyclophosphamide].
Vanrenteghem Y; Roels L; Verberckmoes R; Michielsen P
J Urol Nephrol (Paris); 1975; 81(4-5):281-90. PubMed ID: 1159887
[No Abstract] [Full Text] [Related]
18. Blastic transformation of lymphocytes in in vitro cultures under the influence of phytohemagglutinin and pokeweek mitogen in patients with glomerulonephritis treated over long periods of time with immunosuppressive drugs.
Szewczyk Z; Klinger M; Melcer H
Arch Immunol Ther Exp (Warsz); 1976; 24(1):137-42. PubMed ID: 1259531
[TBL] [Abstract][Full Text] [Related]
19. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
[TBL] [Abstract][Full Text] [Related]
20. [Effect of immunosuppressive, anticoagulant and anti-inflammatory agents on experimental glomerulonephritis. IV. Encorton and immuran].
Gawlik Z; Juska D; Lewandowska T; Tyszkiewicz Z
Patol Pol; 1984; 35(1):77-90. PubMed ID: 6493824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
